ImExHS (IME) Stock Price, News & Analysis

Company Overview

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is headquartered in Mascot, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 2.09 million shs
• Average Volume: N/A
• Market Capitalization: A$18.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IME Stock Analysis - Frequently Asked Questions

How were ImExHS's earnings last quarter?

ImExHS Limited (ASX:IME) posted its earnings results on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter. ImExHS had a negative net margin of 13.82% and a negative trailing twelve-month return on equity of 22.00%.

Company Calendar

• Last Earnings: 2/28/2019
• Today: 7/10/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:IME
• CIK: N/A
• Web: imexhs.com
• Phone: 57 1 316 4890
• Fax: N/A
• Employees: 400
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$3.42 million
• Net Margins: -13.82%
• Pretax Margin: N/A
• Return on Equity: -22.00%
• Return on Assets: -7.48%

Debt

• Debt-to-Equity Ratio: 6.30
• Current Ratio: 1.57
• Quick Ratio: 1.24

Sales & Book Value

• Annual Sales: A$24.90 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.50
• Book Value: A$0.34 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 45,620,000
• Free Float: N/A
• Market Cap: A$18.36 million
• Optionable: Not Optionable
• Beta: 1.20